Abstract
Substantial evidence suggests that non-coding RNA plays a vital role in human cancer, especially long non-coding RNA (lncRNA) with a length greater than 200nt. Herein, we found a lncRNA facilitating human colorectal cancer (CRC) progression. DLGAP1-AS2 was significantly increased in CRC tissues and cell lines. Knockdown of DLGAP1-AS2 inhibited CRC cell proliferation, migration, invasion in vitro, and tumor growth in vivo. The subcellular localization of DLGAP1-AS2 was translocated from the cytoplasm of normal cells to the nucleus of CRC cells due to reduced levels of N6-methyladenosine (m6A) modification. Further, through the screening of a series of signal pathways, we found that Myc pathway was involved in the effect of DLGAP1-AS2. Silencing of DLGAP1-AS2 markedly reduced Myc mRNA and protein levels. Blockade of Myc effectively abolished the enhanced aggressive behaviors of CRC cells caused by DLGAP1-AS2 overexpression. Mechanistically, DLGAP1-AS2 directly bound CTCF, a well-known transcriptional repressor of Myc, resulting in reduced binding of CTCF on Myc promoter and activating Myc transcription. The second hairpin structure of DLGAP1-AS2 was critical for the interaction between DLGAP1-AS2 and CTCF in the nucleus. Taken together, our study reveals the oncogenic regulatory axis of DLGAP1-AS2/CTCF/Myc in CRC, implying a promising targeted therapy for clinical application.
Similar content being viewed by others
Data availability
The data in this study are available from the corresponding author upon request.
References
Ali T, Grote P (2020) Beyond the RNA-dependent function of LncRNA genes. Elife. https://doi.org/10.7554/eLife.60583
Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96(4):1297–1325
Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J Cell Biol 220:2
Chen K, Zhang Z, Yu A, Li J, Liu J, Zhang X (2020) lncRNA DLGAP1-AS2 knockdown inhibits hepatocellular carcinoma cell migration and invasion by regulating miR-154–5p methylation. Biomed Res Int 2020:6575724
Dai D, Wang H, Zhu L, Jin H, Wang X (2018) N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis 9(2):124
Dekker E, Tanis PJ, Vleugels J, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394(10207):1467–1480
Ferre F, Colantoni A, Helmer-Citterich M (2016) Revealing protein-lncRNA interaction. Brief Bioinform 17(1):106–116
Ghanam AR, Bryant WB, Miano JM (2022) Of mice and human-specific long noncoding RNAs. Mamm Genome 33(2):281–292
He L, Li H, Wu A, Peng Y, Shu G, Yin G (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18(1):176
Hu BB, Wang XY, Gu XY, Zou C, Gao ZJ, Zhang H, Fan Y (2019) N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer 18(1):178
Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L (2020) IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ 27(6):1782–1794
Li B, Zhang G, Wang Z, Yang Y, Wang C, Fang D, Liu K, Wang F, Mei Y (2021) c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA. Cell Death Dis 12(11):1006
Llombart V, Mansour MR (2021) Therapeutic targeting of “undruggable” MYC. EBioMedicine 75:103756
Lu J, Xu Y, Xie W, Tang Y, Zhang H, Wang B, Mao J, Rui T, Jiang P, Zhang W (2021) Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer. Cell Death Discov 7(1):255
Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z (2019) The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol 12(1):121
Meyer KD, Jaffrey SR (2014) The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol 15(5):313–326
Miao W, Li N, Gu B, Yi G, Su Z, Cheng H (2020) LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression. J Biochem 167(4):411–418
Peng WX, Koirala P, Mo YY (2017) LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36(41):5661–5667
Qi Y, Shan Y, Li S, Huang Y, Guo Y, Huang T, Zhao X, Jia L (2021) LncRNA LEF1-AS1/LEF1/FUT8 Axis mediates colorectal cancer progression by regulating alpha1, 6-Fucosylationvia Wnt/beta-catenin pathway. Dig Dis Sci. https://doi.org/10.1007/s10620-021-07051-w
Ren C, Zhang Z, Wang S, Zhu W, Zheng P, Wang W (2020) Circular RNA hsa_circ_0001178 facilitates the invasion and metastasis of colorectal cancer through upregulating ZEB1 via sponging multiple miRNAs. Biol Chem 401(4):487–496
Ross CJ, Ulitsky I (2022) Discovering functional motifs in long noncoding RNAs. Wiley Interdiscip Rev RNA. https://doi.org/10.1002/wrna.1708
Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, He E, Shen B, He C (2017) YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. https://doi.org/10.7554/eLife.3131
Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5(10):1024–1039
Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, Li G, Wang G, Song J, Li Z, Zhang Z, Yuan W, Li X (2019) YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene 38(14):2627–2644
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71(3):209–249
Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (lond) 41(2):109–120
Wancata LM, Banerjee M, Muenz DG, Haymart MR, Wong SL (2016) Conditional survival in advanced colorectal cancer and surgery. J Surg Res 201(1):196–201
Wang L, Tang L, Ge T, Zhu F, Liu D, Guo H, Qian P, Xu N (2021) LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer. Bmc Pulm Med 21(1):277
Widagdo J, Anggono V, Wong JJ (2021) The multifaceted effects of YTHDC1-mediated nuclear m(6)A recognition. Trends Genet. https://doi.org/10.1016/j.tig.2021.11.005
Xu L, Huan L, Guo T, Wu Y, Liu Y, Wang Q, Huang S, Xu Y, Liang L, He X (2020) LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1alpha. Oncogene 39(46):7005–7018
Yang C, Hu Y, Zhou B, Bao Y, Li Z, Gong C, Yang H, Wang S, Xiao Y (2020) The role of m(6)A modification in physiology and disease. Cell Death Dis 11(11):960
Yuan J, Song Y, Pan W, Li Y, Xu Y, Xie M, Shen Y, Zhang N, Liu J, Hua H, Wang B, An C, Yang M (2020) LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5. Oncogene 39(43):6664–6676
Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20(10):608–624
Zhong L, Ming Z, Xie G, Fan C, Piao X (2020) Recent advances on the semi-supervised learning for long non-coding RNA-protein interactions prediction: a review. Protein Pept Lett 27(5):385–391
Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, Zeng H, Qin Y, Wan X, Qiao Y, Qiu Y, Teng Y, Liu M (2021) A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene 40(9):1609–1627
Author information
Authors and Affiliations
Contributions
CFR: designed this study and wrote the draft; HBH, JJP, and QC: performed all experiments and collected data; CFR, WHW, XBG, and JB: provided technical assistance and guidance. All authors approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no financial conflicts of interest.
Ethical approval
This study was approved by the Medical Ethics Committee and Institutional Animal Care and Use Committee (IACUC) of the First Affiliated Hospital of Zhengzhou University.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ren, C., Han, H., Pan, J. et al. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc. Mamm Genome 33, 672–683 (2022). https://doi.org/10.1007/s00335-022-09963-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-022-09963-y